Related to Lonza to Provide Cell-Line and Process-Development Services for Athera’s mAb

• Millipore and Roka Bioscience to Develop Molecular Tests for Biopharmaceutical Manufacturing
  
• Pervasis Pockets $17M to Progress Therapeutics for Vascular Repair
  
• Celera and Medco to Assess Effect of KIF6 Testing on Compliance with Statins
  
• China Biologic Allies with Chinese Institute to Improve Production of Plasma-Based Products
  
• Arginetix Pockets $10.75M to Further R&D of Arginase Inhibitors
  
• Merck KGaA and Lonza Separately Acquire Indian Bioscience Companies
  
• Novavax Taps Xcellerex to Bolster Flu Vaccine Production
  
• ArmaGen Chooses PacificGMP to Manufacture Fusion Protein for Phase I Trial in Stroke and Parkinson’s
  
• Evotec Earns Roughly $3.75M as Seventh Milestone Fee from Boehringer Ingelheim
  
• Lonza Takes Over Algonomics for Immunogenicity Prediction Tools for Biologics
  
• Wanbang to Advance D-Pharm’s Late-Stage Stroke Therapy in China
  
• ProMetic to Provide Halozyme with Synthetic Ligand Affinity Adsorbent
  
• Talecris Pours $268.7M into Production Plant in North Carolina
  
• PGxHealth Introduces Molecular Diagnostic for Dilated Cardiomyopathy
  
• Researchers Discover Potential Mechanism for Preventing Cell Death After Stroke
  
• Novartis Inaugurates $1B U.S. Cell Culture Flu Vaccine Facility
  
• The Medicines Company Receives Label Expansion for Anticoagulant
  
• BioLife to Produce Custom Biopreservation Media for Centocor
  
• Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab
  
• Novartis Signs Four-Year Deal with Horizon for Custom-Generated X-Man Cancer Models